Risk of Major Adverse Cardiovascular Events Following Nicotinamide Exposure
In this retrospective cohort study of 13 108 adults from 2 different patient populations, there was no increased risk of MACE in patients with nicotinamide exposure.
Authors
- Lydia Yao
- Themistocles L. Assimes (ORCID: https://orcid.org/0000-0003-2349-0009)
- Lori Churby
- Luis E. Selva (ORCID: https://orcid.org/0000-0002-3098-3832)
- Michael E. Matheny (ORCID: https://orcid.org/0000-0003-3217-4147)
- Jessica V. Brewer
- Yaomin Xu (ORCID: https://orcid.org/0000-0002-3752-4006)
- Lee Wheless (ORCID: https://orcid.org/0000-0002-8162-5971)
- Jefferson L. Triozzi (ORCID: https://orcid.org/0000-0002-3607-6838)
- Kristin Bibee (ORCID: https://orcid.org/0000-0002-7851-9633)
- Otis D. Wilson
- J. Michael Gaziano
- Scott L. DuVall (ORCID: https://orcid.org/0000-0002-4898-3865)
- Deepak Voora (ORCID: https://orcid.org/0000-0003-0015-5179)
- Rebecca I. Hartman (ORCID: https://orcid.org/0000-0001-5559-9100)
- Kelly Cho (ORCID: https://orcid.org/0000-0003-1727-7076)
- Jennifer E. Deen
- Quinn S. Wells (ORCID: https://orcid.org/0000-0003-3899-0313)
- Hua‐Chang Chen (ORCID: https://orcid.org/0000-0003-0497-2483)
- Shahpoor Alex Shayan
- Saiju Pyarajan (ORCID: https://orcid.org/0000-0002-9047-3762)
- Adriana M. Hung (ORCID: https://orcid.org/0000-0002-3203-1608)
- Philip S. Tsao (ORCID: https://orcid.org/0000-0001-7274-9318)
- Brady M. Stephens
- Elizabeth R. Hauser (ORCID: https://orcid.org/0000-0003-0367-9189)
- Amy M. Kilbourne (ORCID: https://orcid.org/0000-0001-5815-6401)
- Christopher Madden (ORCID: https://orcid.org/0000-0003-1154-177X)
- Henry R. Kranzler (ORCID: https://orcid.org/0000-0002-1018-0450)
- Stacey B. Whitbourne (ORCID: https://orcid.org/0000-0002-3472-3464)
- Mary T. Brophy (ORCID: https://orcid.org/0000-0003-2314-4368)
- Ran Tao (ORCID: https://orcid.org/0000-0002-1106-2923)
- Robert J. Ringer
- Siwei Zhang (ORCID: https://orcid.org/0009-0005-0873-5217)
- Jennifer Moser
- Basia Michalski-McNeely
- Rachel B. Weiss
- Dave Oslin
- Sumitra Muralidhar
- Katlyn M. Gonzalez
- Ranya Guennoun
Institutions
- Brigham and Women's Hospital (US)
- State University of New York (US)
- SUNY Downstate Health Sciences University (US)
- Vanderbilt University (US)
- Washington University in St. Louis (US)
- VA Boston Healthcare System (US)
- VA Tennessee Valley Healthcare System (US)
- University of Virginia (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1001/jamadermatol.2025.0001
- Citations
- 6
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 6.27